Literature DB >> 28138610

Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma?

Rosa M Pascale1, Diego F Calvisi1, Francesco Feo1.   

Abstract

Entities:  

Year:  2016        PMID： 28138610      PMCID： PMC5244615          DOI： 10.21037/tgh.2016.05.04

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  20 in total

Review 1.  Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.

Authors:  Maddalena Frau; Fiorella Biasi; Francesco Feo; Rosa M Pascale
Journal:  Mol Aspects Med       Date:  2010-02-20

Review 2.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

3.  Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.

Authors:  Maryse Delehedde; Malcolm Lyon; John T Gallagher; Philip S Rudland; David G Fernig
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 4.  The relevance of the TGF-β Paradox to EMT-MET programs.

Authors:  Chevaun D Morrison; Jenny G Parvani; William P Schiemann
Journal:  Cancer Lett       Date:  2013-03-05       Impact factor: 8.679

Review 5.  Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Authors:  Jin-Ping Lai; James R Thompson; Dalbir S Sandhu; Lewis R Roberts
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

6.  MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.

Authors:  Longlong Bao; Yan Yan; Can Xu; Weidan Ji; Shuwen Shen; Gaoya Xu; Yong Zeng; Bin Sun; Haihua Qian; Lei Chen; Mengchao Wu; Changqing Su; Jie Chen
Journal:  Cancer Lett       Date:  2013-05-14       Impact factor: 8.679

Review 7.  Antagonistic functional duality of cancer genes.

Authors:  A A Stepanenko; Y S Vassetzky; V M Kavsan
Journal:  Gene       Date:  2013-08-09       Impact factor: 3.688

Review 8.  Regulation of EMT by Notch signaling pathway in tumor progression.

Authors:  Yumei Li; Jia Ma; Xiujuan Qian; Qiong Wu; Jun Xia; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Curr Cancer Drug Targets       Date:  2013-11       Impact factor: 3.428

Review 9.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

10.  QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis.

Authors:  Shouwen Wang; Xingbin Ai; Stephen D Freeman; Mary E Pownall; Qun Lu; Daniel S Kessler; Charles P Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205
View more
  3 in total

1.  Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin.

Authors:  Salma Abdi Mahmoud; Mohammed Mohammed Ibrahim; Ahmed Hago Musa; Yuhong Huang; Jun Zhang; Jingwen Wang; Yuanyi Wei; Li Wang; Shunting Zhou; Boyi Xin; Wei Xuan; Jianwu Tang
Journal:  J Cell Commun Signal       Date:  2017-12-23       Impact factor: 5.782

2.  Overexpression of DDIT4 and TPTEP1 are associated with metastasis and advanced stages in colorectal cancer patients: a study utilizing bioinformatics prediction and experimental validation.

Authors:  Fahimeh Fattahi; Jafar Kiani; Mahdi Alemrajabi; Ahmadreza Soroush; Marzieh Naseri; Mohammad Najafi; Zahra Madjd
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

3.  Context Dependent Sulf1/Sulf2 Functional Divergence in Endothelial Cell Activity.

Authors:  Tiago Justo; Nicola Smart; Gurtej K Dhoot
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.